Inspire Medical Systems, Inc.
INSP Healthcare Medical Devices
Inspire Medical Systems, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $912.0 million, up 13.6% from fiscal 2024. In the quarter to June 2026, revenue fell 7.60%, EPS grew 108.3% and free cash flow grew 322.8%, each against the same quarter a year earlier. Revenue growth for five consecutive years.
Follow INSP
Inspire Medical Systems, Inc. (INSP) P/E ratio
As of 16 October 2026, Inspire Medical Systems, Inc. (INSP) trades at a P/E ratio of 14.8×. Over the past ten years it has ranged from 0.0× (June 2024) to 1,084× (September 2024); the current reading is higher than 80% of that period. That is below the Medical Devices industry median of 23.2× and below the Healthcare sector median of 23.0×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 18.4× | (82.26%) |
| FY2024 | 104× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 0.0× | — |
| FY2020 | 0.0× | — |
| FY2019 | 0.0× | — |
| FY2018 | 0.0× | — |
| FY2017 | 0.0× | — |
| FY2016 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 9.6× | (15.93%) |
| Mar 2026 | 11.4× | (38.03%) |
| Dec 2025 | 18.4× | (62.86%) |
| Sep 2025 | 49.5× | (32.15%) |
| 34 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| BFLY Butterfly Network, Inc. compare | n/m |
| ESTA Establishment Labs Holdings Inc. compare | n/m |
| NEOG Neogen Corporation compare | n/m |
| NVCR NovoCure Limited compare | n/m |
| AXGN AxoGen, Inc. compare | n/m |
| ATEC Alphatec Holdings, Inc. compare | n/m |
| INSP Inspire Medical Systems, Inc. | 14.8× |
| TMDX TransMedics Group, Inc. compare | 16.0× |
| UFPT UFP Technologies, Inc. compare | 31.2× |
| Medical Devices industry median | 23.2× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)